Barcelona Macula Foundation collaborates with the Institut de la Màcula i de la Retina in a programme of clinical trials for researching new treatments for vision diseases. The Institut’s clinical trials programme offers access to the latest treatments, with no cost to the patient and with a duration between 1 and 2 years.
Clinical trials are the only means of access to the new medicines that are as yet unavailable on the market. At present, there are many incurable eye diseases and research into new techniques and drugs is needed to confirm their efficacy and set out on the path to treatment and cure.
From the outset, the Institut de la Màcula i de la Retina has undertaken clinical trials that enable us to research new treatments or new ways of using existing ones in order to cure diseases and rescue patients from vision loss.
The Institut is currently working on several clinical trials. It is recruiting patients who are affected by age-related macular degeneration (AMD), both in the dry (or atrophic) and the wet (or exudative) forms of the disease, neovascular glaucoma and vitreomacular traction syndrome.
If you are interested in taking part in a clinical trial, please call us at 935 950 155 and we will assess whether you are eligible.
Further information on trials at the video.